Literature DB >> 28505492

Comprehensive evaluation of SCFA production in the intestinal bacteria regulated by berberine using gas-chromatography combined with polymerase chain reaction.

Lu-Lu Wang1, Hui-Hui Guo2, Shuai Huang2, Chen-Lin Feng2, Yan-Xing Han3, Jian-Dong Jiang4.   

Abstract

Short-chain fatty acids (SCFAs) of intestine microbial have caught accumulating attention for their beneficial effects on human health. Botanic compounds with low bioavailability such as berberine (BBR) and resveratrol might interact with intestinal microbial ecosystem and promote gut bacteria to produce SCFA, which contribute to their biological effects. In the present study, a comprehensive assay system was built to detect SCFAs production in intestinal bacteria, in which stringent anaerobic culture was applied for in vitro bacterial fermentation, followed by direct-injection GC detection (chemical detection) in combination with real time polymerase chain reaction (RT-PCR, biological detection). BBR was used as positive reference. The direct injection GC method was calibrated and successfully applied to analyze the concentration of SCFAs in gut microbiota and BBR was proved to be effective in the dose- and time-dependent up-regulation of SCFAs production. As compared to the saline group, the concentration of acetic acid, propionate acid and butyric acid (the main SCFAs in gut microbiota) were increased by 17.7%, 11.1% and 30.5%, respectively, after incubating intestinal bacteria with 20μg/mL BBR for 24h. The increase reached to 34.9%, 22.4% and 51.6%, respectively when the BBR was 50μg/mL. Additionally, consensus-degenerate hybrid oligonucleotide primers (CODEHOPs) were designed for the detection of acetate kinase (ACK), Methylmalonyl-CoA decarboxylase (MMD) and butyryl-CoA: acetate-CoA transferase (BUT), as they are the key enzymes in the synthetic pathway for acetic acid, propionate acid and butyric acid, respectively. After 24hr's incubation, BBR was shown to promote the gene expression of ACK, MMD and BUT significantly (86.5%, 27.2% and 60.4%, respectively, with 20μg/mL BBR; 130.2%, 84.2% and 98.4%, respectively, with 50μg/mL BBR), showing a solid biological support for the chemical detection. This comprehensive assay system might be useful in identifying SCFAs promoting agents with information on their mechanism.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Berberine; Gas chromograph; In vitro fermentation; Intestinal bacteria; Short-chain fatty acids

Mesh:

Substances:

Year:  2017        PMID: 28505492     DOI: 10.1016/j.jchromb.2017.05.004

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  14 in total

1.  The gut microbiota modulator berberine ameliorates collagen-induced arthritis in rats by facilitating the generation of butyrate and adjusting the intestinal hypoxia and nitrate supply.

Authors:  Mengfan Yue; Yu Tao; Yulai Fang; Xingpan Lian; Qin Zhang; Yufeng Xia; Zhifeng Wei; Yue Dai
Journal:  FASEB J       Date:  2019-08-19       Impact factor: 5.191

Review 2.  Nutraceuticals in the Prevention and Treatment of the Muscle Atrophy.

Authors:  Yanan Wang; Qing Liu; Helong Quan; Seong-Gook Kang; Kunlun Huang; Tao Tong
Journal:  Nutrients       Date:  2021-06-02       Impact factor: 5.717

Review 3.  Gut Microbiota, Short-Chain Fatty Acids, and Herbal Medicines.

Authors:  Wuwen Feng; Hui Ao; Cheng Peng
Journal:  Front Pharmacol       Date:  2018-11-23       Impact factor: 5.810

4.  The Chinese Herbal Formula Shenzhu Tiaopi Granule Results in Metabolic Improvement in Type 2 Diabetic Rats by Modulating the Gut Microbiota.

Authors:  Jindong Zhao; Yan Li; Min Sun; Ling Xin; Tianming Wang; Liangbing Wei; Chanjuan Yu; Mengmeng Liu; Yingqun Ni; Ruimin Lu; Taotao Bao; Lu Zhang; Yuanyuan Wu; Zhaohui Fang
Journal:  Evid Based Complement Alternat Med       Date:  2019-06-04       Impact factor: 2.629

Review 5.  Involvement of Gut Microbiota, Microbial Metabolites and Interaction with Polyphenol in Host Immunometabolism.

Authors:  Andy W C Man; Yawen Zhou; Ning Xia; Huige Li
Journal:  Nutrients       Date:  2020-10-06       Impact factor: 5.717

6.  Dietary supplementation with berberine improves growth performance and modulates the composition and function of cecal microbiota in yellow-feathered broilers.

Authors:  Cui Zhu; Kaiyong Huang; Yinshan Bai; Xin Feng; Li Gong; Chuangxin Wei; Hanze Huang; Huihua Zhang
Journal:  Poult Sci       Date:  2020-11-19       Impact factor: 3.352

7.  Effect of berberine on hyperglycaemia and gut microbiota composition in type 2 diabetic Goto-Kakizaki rats.

Authors:  Jin-Dong Zhao; Yan Li; Min Sun; Chan-Juan Yu; Jia-Yun Li; Si-Hai Wang; Di Yang; Cheng-Lin Guo; Xue Du; Wen-Jin Zhang; Ruo-Dong Cheng; Xiao-Chuan Diao; Zhao-Hui Fang
Journal:  World J Gastroenterol       Date:  2021-02-28       Impact factor: 5.742

Review 8.  Effects of Berberine on the Gastrointestinal Microbiota.

Authors:  Lichao Zhang; Xiaoying Wu; Ruibing Yang; Fang Chen; Yao Liao; Zifeng Zhu; Zhongdao Wu; Xi Sun; Lifu Wang
Journal:  Front Cell Infect Microbiol       Date:  2021-02-19       Impact factor: 5.293

9.  Resveratrol Improves Growth Performance, Intestinal Morphology, and Microbiota Composition and Metabolism in Mice.

Authors:  Yu Zhuang; Huijun Huang; Shuang Liu; Feng Liu; Qiang Tu; Yulong Yin; Shanping He
Journal:  Front Microbiol       Date:  2021-09-03       Impact factor: 5.640

Review 10.  Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota.

Authors:  Shengjie Yang; Dan Li; Zongliang Yu; Yujuan Li; Min Wu
Journal:  Front Pharmacol       Date:  2021-07-09       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.